1. Home
  2. NFE vs EVAX Comparison

NFE vs EVAX Comparison

Compare NFE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

N/A

Current Price

$4.16

Market Cap

24.6M

Sector

Utilities

ML Signal

N/A

Logo Evaxion Biotech

EVAX

Evaxion Biotech

N/A

Current Price

$2.97

Market Cap

25.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NFE
EVAX
Founded
2014
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
25.5M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
NFE
EVAX
Price
$4.16
$2.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
★ 417.6K
116.3K
Earning Date
11-20-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,504,037,000.00
N/A
Revenue This Year
$108.26
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$2.72
52 Week High
$16.90
$6.92

Technical Indicators

Market Signals
Indicator
NFE
EVAX
Relative Strength Index (RSI) 48.79 45.34
Support Level $0.40 $2.90
Resistance Level $7.13 $3.56
Average True Range (ATR) 0.37 0.38
MACD 0.07 -0.05
Stochastic Oscillator 57.23 12.28

Price Performance

Historical Comparison
NFE
EVAX

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. It owns and operates natural gas and liquefied natural gas (LNG) infrastructure, and an integrated fleet of ships and logistics assets to deliver turnkey energy solutions to markets globally. The company's reportable segments are: Terminals and Infrastructure, and Ships. Maximum revenue is generated from the Terminals and Infrastructure segment, which includes vertically integrated gas-to-power solutions, spanning the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, facilities, and conversion or development of natural gas-fired power generation. Vessels that are utilized in the company's terminal, logistics, or sub-charter operations are included in this segment.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: